Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:50 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III L.P. | 906,486 5.000% |
82,860 (+10.06%) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Venrock Healthcare Capital Partners III L.P. | 3,541,941 9.990% |
3,541,941 (New Position) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Venrock Healthcare Capital Partners III L.P. | 13,760,200 8.700% |
5,984,440 (+76.96%) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
Venrock Healthcare Capital Partners III L.P. | 4,026,331 8.500% |
1,071,429 (+36.26%) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN |
Venrock Healthcare Capital Partners III L.P. | 3,565,841 8.100% |
1,000,000 (+38.97%) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 11,656,065 9.990% |
3,778,248 (+47.96%) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH |
Venrock Healthcare Capital Partners III L.P. | 1,744,373 5.900% |
816,667 (+88.03%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Cabaletta Bio, Inc. CABA |
Venrock Healthcare Capital Partners III L.P. | 1,590,696 3.300% |
-973,256 (-37.96%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III L.P. | 5,389,259 6.400% |
1,984,126 (+58.27%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Celcuity Inc. CELC |
Venrock Healthcare Capital Partners III L.P. | 0 0.000% |
-2,476,980 (Position Closed) |
Filing History |
| 2024-11-14 5:45 pm Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
Venrock Healthcare Capital Partners III L.P. | 3,458,645 6.100% |
232,839 (+7.22%) |
Filing History |
| 2024-08-19 4:15 pm Purchase |
2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX |
Venrock Healthcare Capital Partners III L.P. | 355,224 9.990% |
355,224 (New Position) |
Filing History |
| 2024-08-01 4:18 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
Venrock Healthcare Capital Partners III L.P. | 1,609,569 6.900% |
1,609,569 (New Position) |
Filing History |
| 2024-07-25 8:48 pm Purchase |
2024-07-15 | 13G | CASI Pharmaceuticals, Inc. CASI |
Venrock Healthcare Capital Partners III L.P. | 1,507,040 9.990% |
1,507,040 (New Position) |
Filing History |
| 2024-06-24 4:15 pm Purchase |
2024-06-13 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC |
Venrock Healthcare Capital Partners III L.P. | 750,000 8.400% |
750,000 (New Position) |
Filing History |
| 2024-05-31 4:18 pm Purchase |
2024-05-21 | 13G | Erasca, Inc. ERAS |
Venrock Healthcare Capital Partners III L.P. | 16,216,216 6.500% |
16,216,216 (New Position) |
Filing History |
| 2024-05-02 4:16 pm Purchase |
2024-04-22 | 13G | Zura Bio Limited ZURA |
Venrock Healthcare Capital Partners III L.P. | 6,399,619 9.990% |
6,399,619 (New Position) |
Filing History |
| 2024-04-29 7:28 pm Purchase |
2024-04-17 | 13G | ARCA biopharma, Inc. ABIO |
Venrock Healthcare Capital Partners III L.P. | 62,889 5.200% |
62,889 (New Position) |
Filing History |
| 2024-04-01 6:21 pm Purchase |
2024-03-22 | 13G | Aquestive Therapeutics, Inc. AQST |
Venrock Healthcare Capital Partners III L.P. | 5,555,555 6.500% |
5,555,555 (New Position) |
Filing History |
| 2024-03-04 4:16 pm Purchase |
2024-02-21 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III L.P. | 3,405,133 5.400% |
3,405,133 (New Position) |
Filing History |